By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > GMJ Briefs > 🚨 Meningitis B: UK launches vaccine programme to protect students after fatal outbreaks

🚨 Meningitis B: UK launches vaccine programme to protect students after fatal outbreaks

GMJ
Last updated: 21/06/2026 01:05
By
Prof. Giorgi Pkhakadze
Share
1 Min Read
SHARE
1 min read|101 words
🚨 Breaking Newsvia BMJ Latest

Thousands of young people across England, Wales, and Scotland will be offered the meningitis B (MenB) vaccine for the first time this summer.123Eligible students—those finishing year 13 this summer (aged 17 and 18), together with people under 25 starting university or other residential further education—will be offered two doses of the vaccine, at least four weeks apart, before they start further education this autumn.The programme is being launched after the major outbreak seen in Kent in March, which led to…

This is a developing story.

Source: Meningitis B: UK launches vaccine programme to protect students after…

Was this article helpful?

Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByProf. Giorgi Pkhakadze
Follow:
Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
Climate Crisis Threatens 2.2 Billion Children’s Health and Wellbeing, UNICEF Reports

UNICEF reports that over 2.2 billion children worldwide face heightened health risks…

GIS Mapping and Local Knowledge Cut Medical Supply Delays in Nigerian Flood Zones by 40%

New research shows that combining GIS mapping with community knowledge reduces medical…

One in Four Postpartum Women in Kenya Experience Severe Menstrual Pain, Study Finds

New research from Western Kenya finds 24% of postpartum women experience moderate-to-severe…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Global HealthPolicy & Systems

Malaria Cases Rising in Five African Countries Despite Global Control Efforts

By
Prof. Giorgi Pkhakadze
26/05/2026
Global HealthPolicy & Systems

WHO Declares Emergency as Rare Ebola Strain Crosses DRC-Uganda Border

By
Prof. Giorgi Pkhakadze
31/05/2026
Abstract visualization of AI assisting with scientific research and data analysis

The AI Co-Scientist Promise: Why Hype Outpaces Evidence

By
Prof. Giorgi Pkhakadze
03/06/2026
Medical illustration showing hepatitis B virus and treatment breakthrough concept

GSK’s Experimental Hepatitis B Drug Shows Promise in Phase 2 Trials

By
Prof. Giorgi Pkhakadze
04/06/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up